| Dr Diana Dee Mills-maloney, MD | |
|
10312 Creek Meadow Dr, Oklahoma City, OK 73151-9138 | |
| (405) 771-3577 | |
| Not Available |
| Full Name | Dr Diana Dee Mills-maloney |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Location | 10312 Creek Meadow Dr, Oklahoma City, Oklahoma |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013277284 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 11261 (Oklahoma) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Diana Dee Mills-maloney, MD 10312 Creek Meadow Dr, Oklahoma City, OK 73151-9138 Ph: (405) 771-3577 | Dr Diana Dee Mills-maloney, MD 10312 Creek Meadow Dr, Oklahoma City, OK 73151-9138 Ph: (405) 771-3577 |
News Archive
The coronavirus disease (COVID-19) is rapidly spreading across the globe, and containment measures have been implemented at many of the hotspots for the disease. Though isolation and quarantine measures are considered the best way to contain the virus, one new study suggests it might not be as effective as hoped.
One in three nursing home residents who have Alzheimer's disease are not getting their vision corrected so they can see clearly, according to new Saint Louis University research in the July issue of the Journal of the American Medical Directors Association.
A new decision analytical model published in JAMA Network Open by the researchers from China examined a number of vital epidemiological features of imported severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 2019 (COVID-19) cases in the Chinese city of Wenzhou, emphasizing the need for timely community containment.
Stroke is the second leading cause of death in Los Angeles County and the fourth in the U.S. In order to cut those numbers, it's imperative that new treatments be developed and refined for stroke prevention, acute therapy and recovery after stroke.
Fibrocell Science, Inc., a biotechnology company focused on the development of autologous cell therapies for aesthetic, medical and scientific applications, announced today that it has submitted its complete response to the Complete Response (CR) letter issued by the U.S. Food & Drug Administration (FDA) regarding the Company's Biologics License Application (BLA) for azficel-T, proposed brand name laViv®, for the treatment of moderate to severe nasolabial folds and wrinkles.
› Verified 5 days ago
Dr. Hunter Dale Cook, D.O Emergency Medicine Medicare: Medicare Enrolled Practice Location: 4401 S Western Ave, Oklahoma City, OK 73109 Phone: 405-636-7709 | |
Alejandro Anzaldua, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 900 Ne 10th St, Fmc 2102, Oklahoma City, OK 73104 Phone: 405-271-2230 | |
Dr. David Brennan, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 4401 S Western Ave, Oklahoma City, OK 73109 Phone: 405-636-7000 | |
Aaron Daniel Jones, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4401 S Western Ave, Oklahoma City, OK 73109 Phone: 405-636-7000 | |
Dr. David M. Abercrombie, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1624 Grey Fox Run, Oklahoma City, OK 73131 Phone: 405-478-3969 Fax: 405-478-3815 | |
Dr. Amy L. Sparkman, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 940 Ne 13th St, Oklahoma City, OK 73104 Phone: 405-271-2429 |